Key facts
- This page summarizes Roberto A. Mignone's Form 4 filing for Guardant Health, Inc. (GH).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2024, 18:06.
Roberto A. Mignone - 08 Nov 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- Director
- Issuer ticker
- GH
- Reported as of
- 08 Nov 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2024, 18:06:14 UTC
- Prior SEC filing
- 29 Oct 2024
- Next SEC filing
- 26 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John G. Saia, as attorney-in-fact for Roberto A. Mignone
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Roberto A. Mignone filed Form 4 for Guardant Health, Inc. (GH) on 12 Nov 2024.
Change
- Previous filing in this sequence was filed on 29 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +19,535
- Change %
- Price
- $0.000000
- Shares after
- 19,535
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,535
- Exercise price
- $28.61
- Footnotes
- F1
GH
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +12,671
- Change %
- Price
- $0.000000
- Shares after
- 12,671
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,671
- Exercise price
- $0.000000
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The stock option granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of October 21, 2024, and the remaining 75% vests monthly for the three-year period thereafter.
Footnote F2
The restricted stock unit granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of October 21, 2024, and the remaining 75% vests monthly for the three-year period thereafter.
Footnote F3
Not applicable for Restricted Stock Units.